Deputy Clerkship Director; Associate Professor of Medicine
Brooke Army Medical Center
Disclosure: I do not have any relevant financial / non-financial relationships with any proprietary interests.
Dr David Lindholm is an Associate Professor and the Deputy Clerkship Director in the Department of Medicine at the Uniformed Services University of the Health Sciences (USUHS), serving as the site director for the medicine clerkship rotation at Brooke Army Medical Center (BAMC) in San Antonio, TX. He graduated from Cedarville University (Ohio) with a Bachelor of Science in chemistry and commissioned into the US Air Force through the Reserve Officer Training Corps in 2007. He earned his Doctor of Medicine from USUHS in 2011. He completed both his residency in internal medicine (2014) and fellowship in infectious disease (2016) at BAMC, achieving board certification in both specialties. He then completed a two-year tour at the Wright-Patterson Medical Center (WPMC) in Dayton, OH, where he served as chief of the infectious disease element, chair of the hospital’s antimicrobial stewardship and infection control programs, and faculty for the Wright State University Internal Medicine Residency. He was recognized as the subspecialist of the year by the WPMC Department of Medicine for the 2017-2018 academic year. Having returned to San Antonio in August 2018 with USUHS, he also serves as core faculty for the San Antonio Uniformed Services Health Education Consortium (SAUSHEC) Infectious Disease Fellowship and as the subspecialty education coordinator for infectious disease for the SAUSHEC Internal Medicine Residency. He is a fellow of the American College of Physicians, past President of the Armed Forces Infectious Diseases Society, and lecturer at the annual US Air Force School of Aerospace Medicine Global Medicine Symposium and USUHS Military Tropical Medicine Course on the topics of malaria, travel medicine, and respiratory infections. He also taught internationally with the Defense Institute for Medical Operations on infection control and pandemic management. He is the site principal investigator for the EPICC (Epidemiology, Immunology and Clinical Characteristics of Emerging Infectious Diseases with Pandemic Potential) natural history study of COVID-19 and the National Institute of Allergy and Infectious Diseases-sponsored Adaptive COVID-19 Treatment Trial. His current research interests include emerging infectious diseases, medical education, and travel/tropical medicine.
